3 free views remaining today
polycystic kidney disease 7
ICD-10 Codes
Related ICD-10:
Description
Polycystic Kidney Disease (PKD) Description
Polycystic kidney disease (PKD) is a multisystemic and progressive disorder characterized by cyst formation and enlargement in the kidney and other organs, such as the liver, pancreas, and arteries [7]. This genetic condition leads to the development of numerous fluid-filled sacs, called cysts, which grow in both kidneys, eventually causing them to become enlarged.
Key Features:
- Multisystemic disorder affecting multiple organs
- Progressive nature leading to kidney damage and failure
- Cyst formation and enlargement in the kidneys and other organs
This condition is a significant health concern, as it can lead to kidney failure if left untreated. Understanding the description of PKD is crucial for early detection and management.
References:
[7] Aug 15, 2023 — It is a multisystemic and progressive disorder characterized by cyst formation and enlargement in the kidney and other organs (eg, liver, ...
Additional Characteristics
- a multisystemic and progressive disorder
- characterized by cyst formation and enlargement in the kidney and other organs
- such as the liver, pancreas, and arteries
- leads to the development of numerous fluid-filled sacs, called cysts
- grow in both kidneys, eventually causing them to become enlarged
Signs and Symptoms
Symptoms of Autosomal Dominant PKD
Polycystic Kidney Disease (PKD) can manifest in various ways, and its symptoms can vary from person to person. Some common signs and symptoms of Autosomal Dominant PKD include:
- Back pain and pain in the sides: This is one of the most common complaints among individuals with PKD.
- Urinary tract infections: People with PKD are more prone to developing urinary tract infections due to the presence of cysts in the kidneys.
- Blood in the urine (hematuria): Hematuria can be a sign of kidney damage or disease, and it's often seen in individuals with PKD.
- Liver and/or pancreatic cysts: In some cases, PKD can also affect the liver and pancreas, leading to the formation of cysts.
It's essential to note that not everyone with PKD will experience all of these symptoms. Some people may have mild symptoms or no symptoms at all, while others may experience more severe symptoms. If you're concerned about your health or suspect you might be experiencing symptoms related to PKD, consult a healthcare professional for proper evaluation and guidance.
References:
- [7] Symptoms of Autosomal Dominant PKD · Back pain and pain in the sides · Urinary tract infections · Blood in the urine (hematuria) · Liver and/or pancreatic cysts.
Additional Symptoms
- Urinary tract infections
- Blood in the urine (hematuria)
- or pancreatic cysts
- pain
Diagnostic Tests
Polycystic kidney disease (PKD) can be diagnosed using various tests, including:
- Ultrasonography: This is the most widely used imaging technique to help diagnose ADPKD. It can detect cysts from 1-1.5 cm [8]. An ultrasound scan of your kidneys is likely to be used for diagnosis [9].
- Genetic testing: Genetic testing is done to detect the mutations in the PKD genes. Although expensive, it can be performed when a precise diagnosis is needed and the results of other tests are inconclusive [4].
- Urine tests: Urine tests may also be used as part of the diagnostic process for PKD [3].
- Specialized blood tests: Specialized blood tests, such as those that measure the levels of certain proteins in the blood, may also be used to help diagnose PKD [3].
It's worth noting that the diagnosis of PKD can involve a combination of these tests, and the specific tests used may depend on individual circumstances.
Additional Diagnostic Tests
- Urine tests
- Genetic testing
- Ultrasonography
- Specialized blood tests
Treatment
Current Drug Treatments for Polycystic Kidney Disease (PKD)
Polycystic kidney disease (PKD) is a genetic disorder that causes fluid-filled sacs called cysts to grow in the kidneys. While there is no cure for PKD, various drug treatments can help manage its symptoms and slow down its progression.
- Tolvaptan: This medication has been shown to slow down the growth of kidney cysts and improve kidney function in people with ADPKD (autosomal dominant polycystic kidney disease). It works by blocking the action of vasopressin, a hormone that can contribute to cyst growth.
- Blood pressure management: High blood pressure is common in people with PKD. Managing blood pressure through medication, diet, and lifestyle changes can help slow down kidney damage.
- Antibiotics for infected cysts: If kidney or liver cysts become infected, antibiotics can be used to treat the infection.
Emerging Treatments
Recent studies have also explored other potential treatments for PKD, including:
- Glycosides: Researchers have discovered that certain glycoside drugs may be able to sidestep the effects of the defective gene responsible for PKD.
- Lowering cAMP levels: Some clinical trials have investigated the use of medications that lower cyclic adenosine monophosphate (cAMP) levels, which can contribute to cyst growth.
Current Limitations
While these treatments show promise, it's essential to note that there is currently no cure for PKD. Further research is needed to develop more effective and targeted therapies for this condition.
References:
- [1] Tolvaptan slows how fast kidney cysts grow and improves kidney function in people with ADPKD.
- [6] Tolvaptan has been available across the UK since early 2016 and slows the progression of cyst growth in PKD patients.
- [8] Current treatment strategies for PKD include lowering cAMP levels, inhibiting cell proliferation, and reducing fluid secretion.
- [9] Treating infected kidney or liver cysts requires antibiotics that penetrate into the cyst.
Recommended Medications
- Blood pressure management
- Antibiotics for infected cysts
- Glycosides
- Lowering cAMP levels
- tolvaptan
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Polycystic Kidney Disease (PKD)
Polycystic kidney disease (PKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys. When diagnosing PKD, it's essential to consider other conditions that may present with similar symptoms. Here are some differential diagnoses for PKD:
- Congenital Hepatic Fibrosis: This rare condition involves the formation of fibrous tissue in the liver and can be associated with kidney disease.
- Multicystic Renal Dysplasia: A congenital disorder where one or both kidneys develop cysts, which can lead to kidney failure.
- Neonatal Hypertension: High blood pressure in newborns can be a sign of underlying kidney disease, including PKD.
- Pediatric Caroli Disease: A rare condition characterized by the formation of cysts in the bile ducts, which can be associated with kidney disease.
These conditions should be considered in the differential diagnosis for PKD, especially in cases where the patient's symptoms and family history are unclear. Accurate diagnosis is crucial to provide appropriate treatment and management for patients with PKD or other related conditions.
References:
- [7] Nov 19, 2024 — Differential Diagnoses
- [8] by M Alves · 2015 · Cited by 18 — The differential diagnosis between ADPKD and other cystic kidney diseases depends on the age of the patient, family history and the presence of associated manifestations.
Additional Differential Diagnoses
- Congenital Hepatic Fibrosis
- Multicystic Renal Dysplasia
- Neonatal Hypertension
- Pediatric Caroli Disease
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0060952
- core#notation
- DOID:0060952
- oboInOwl#hasDbXref
- MIM:620056
- rdf-schema#label
- polycystic kidney disease 7
- IAO_0000115
- A autosomal dominant polycystic kidney disease characterized by the development of small kidney cysts and renal interstitial fibrosis causing adult-onset progressive loss of kidney function leading to end-stage kidney disease after around 60 years of age that has_material_basis_in heterozygous mutation in the ALG5 gene on chromosome 13q13.
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_898
- relatedICD
- http://example.org/icd10/Q61.3
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- owl#annotatedSource
- t345684
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.